Table 4 Univariate and multivariate logistic regression analysis of poor glycemic control (HbA1c ≥ 7.0%) in the study patients
Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
OR (95% CI) | p value | OR (95% CI) | p value | |
Insulin therapy | 5.70 (2.08–15.67) | < 0.001 |  |  |
n-6/n-3 ratio | 2.69 (1.41–5.14) | 0.003 | 4.35 (1.72–10.96) | 0.002 |
hsCRP (mg/l) | 1.28 (1.01–1.62) | 0.043 | 1.52 (1.04–2.21) | 0.032 |
Total n-6 PUFAs (µmol/l) | 1.25 (1.04–1.50) | 0.020 |  |  |
T2DM duration (years) | 1.11 (1.02–1.21) | 0.019 | 1.18 (1.04–1.32) | 0.008 |
C18:2; LA (µmol/l) | 1.01 (1.001–1.011) | 0.037 |  |  |
C20:5; EPA (µmol/l) | 0.98 (0.97–1.00) | 0.050 |  |  |
Total n-3 PUFAs (µmol/l) | 0.76 (0.63–0.93) | 0.007 |  |  |
C-peptide (ng/ml) | 0.66 (0.45–0.96) | 0.028 |  |  |
EPA/AA ratio | 0.001 (0.0001–0.51) | 0.034 |  |  |